The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of ...

Parexel, a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the launch of the Parexel ...

As it prepares to compete in the KRAS arena, the Japanese pharma has retooled its approach to clinical development.

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

Outlines broad discovery and development efforts targeting synthetic lethality and DNA-damage repair mechanisms, including PRMT5-MTA, SGR-3515 and SGR-2921 programs NEW YORK--(BUSINESS ...

Phase 1/2 FUNCTION ALS trial initiated in Europe with additional global regions anticipated in 2026 First patients dosed in LAUNCH ALS, an investigator-initiated trial in China conducted in partnershi ...

Jeremy Chadwick will retire from his role as Chief Operating Officer WATERTOWN, Mass., June 08, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical ...

WOBURN, Mass.--(BUSINESS WIRE)--ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today that Mr. Tom Shea ...

Fully enrolled, randomized, double-blind, sham-controlled Phase 2 study has completed treatment administration in 99 patients; Company continues ...

Charitharth Vivek Lal, M.D. is program director of the Golden Week Program™, an evidence-based, standardized, quality improvement plan, established and implemented at the UAB Regional Neonatal ...